BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22156850)

  • 1. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization.
    Skowronski DM; Janjua NZ; Tsafack EP; Ouakki M; Hoang L; De Serres G
    Clin Infect Dis; 2012 Feb; 54(3):318-27. PubMed ID: 22156850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy.
    Meregaglia M; Ferrara L; Melegaro A; Demicheli V
    Vaccine; 2013 Feb; 31(8):1135-7. PubMed ID: 23306370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cocoon immunisation strategy against pertussis for infants: does it make sense for Ontario?
    Lim GH; Deeks SL; Crowcroft NS
    Euro Surveill; 2014 Feb; 19(5):. PubMed ID: 24524236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016.
    Desai S; Schanzer DL; Silva A; Rotondo J; Squires SG
    Vaccine; 2018 Nov; 36(49):7568-7573. PubMed ID: 30392765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent and adult pertussis vaccination: computer simulations of five new strategies.
    Van Rie A; Hethcote HW
    Vaccine; 2004 Aug; 22(23-24):3154-65. PubMed ID: 15297068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit of the introduction of new strategies for vaccination against pertussis in Spain: cocooning and pregnant vaccination strategies.
    Fernández-Cano MI; Armadans Gil L; Campins Martí M
    Vaccine; 2015 May; 33(19):2213-2220. PubMed ID: 25825331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in deaths from pertussis among young infants in the United States in the 1990s.
    Vitek CR; Pascual FB; Baughman AL; Murphy TV
    Pediatr Infect Dis J; 2003 Jul; 22(7):628-34. PubMed ID: 12867839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of parental cocooning as a vaccination strategy to prevent pertussis infection in infants: A case-control study.
    Rowe SL; Tay EL; Franklin LJ; Stephens N; Ware RS; Kaczmarek MC; Lester RA; Lambert SB
    Vaccine; 2018 Apr; 36(15):2012-2019. PubMed ID: 29525284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications?
    Takeuchi M; Yasunaga H; Horiguchi H; Matsuda S
    Epidemiol Infect; 2012 Aug; 140(8):1497-502. PubMed ID: 22008091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.
    Binkin NJ; Salmaso S; Tozzi AE; Scuderi G; Greco D; Greco D
    Pediatr Infect Dis J; 1992 Aug; 11(8):653-61. PubMed ID: 1523078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis in early infancy: disease burden and preventive strategies.
    McIntyre P; Wood N
    Curr Opin Infect Dis; 2009 Jun; 22(3):215-23. PubMed ID: 19395958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis hospitalizations among infants in the United States, 1993 to 2004.
    Cortese MM; Baughman AL; Zhang R; Srivastava PU; Wallace GS
    Pediatrics; 2008 Mar; 121(3):484-92. PubMed ID: 18310196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.